Acquired drug resistance in Mycobacterium tuberculosis isolates recovered from compliant patients with human immunodeficiency virus-associated tuberculosis

Clin Infect Dis. 1997 Nov;25(5):1044-7. doi: 10.1086/516065.

Abstract

We describe five compliant patients with human immunodeficiency virus (HIV)-associated tuberculosis (TB) that relapsed, with acquisition of resistance by the original Mycobacterium tuberculosis strains. Both the first and second isolates from each patient had the same IS (insertion sequence) 6110-based DNA fingerprint patterns. Three of the five patients developed TB that was resistant to rifampin alone; no mutation in the region of the rpoB gene was detected by a line probe assay in two of the isolates from these patients. We discuss several factors presumably associated with acquired drug resistance in HIV-infected patients, including exogenous reinfection, drug interactions, malabsorption of drugs, and the presence of a large organism burden.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • AIDS-Related Opportunistic Infections / drug therapy
  • AIDS-Related Opportunistic Infections / microbiology*
  • Antitubercular Agents / therapeutic use*
  • DNA, Bacterial / analysis
  • DNA-Directed RNA Polymerases / genetics
  • Drug Resistance, Microbial
  • Humans
  • Isoniazid / therapeutic use*
  • Mycobacterium tuberculosis / drug effects*
  • Mycobacterium tuberculosis / genetics
  • Mycobacterium tuberculosis / isolation & purification
  • Patient Compliance
  • Rifampin / therapeutic use*
  • Tuberculosis / complications
  • Tuberculosis / drug therapy
  • Tuberculosis / microbiology*

Substances

  • Antitubercular Agents
  • DNA, Bacterial
  • DNA-Directed RNA Polymerases
  • RNA polymerase beta subunit
  • Isoniazid
  • Rifampin